Pelthos Therapeutics PTHS
NYSE PTHS
$20.45 -0.05 (-0.24%)
As of: Oct 21, 2026 · 10:07 AM EDT

Pelthos Therapeutics (PTHS) EBITDA (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) recorded EBITDA of -$16 million in Q2 2026, compared with -$3.23 million a year earlier.

Analysis

Pelthos Therapeutics (PTHS) EBITDA (2025 - 2026) Analysis & Trends

On a TTM basis, Pelthos Therapeutics' EBITDA came in at -$52.67 million as of Jun 30, 2026; for FY2025, it came in at -$30.15 million.

  • Across earlier years, EBITDA came in at -$7.57 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at -$11.59 million (Q1 2026), -$10.47 million (Q4 2025) and -$14.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn 9.10 Bn
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn 8.33 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn -
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn -9.70 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn 5.89 Bn
10 Pelthos Therapeutics 72.38 Mn -16.01 Mn 11.99 Mn -15.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.77 Mn
Mar 31, 2026 -11.39 Mn
Jun 30, 2025 -3.07 Mn
Mar 31, 2025 -1.74 Mn
API Access

Pelthos Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=PTHS&period=max&api_key=YOUR_API_KEY